Comparative Effectiveness of Intravenous Ketamine and Intranasal Esketamine in Clinical Practice Among Patients With Treatment-Refractory Depression
Balwinder Singh(Mayo Clinic), Jennifer L. Vande Voort(Mayo Clinic), Kathryn M. Schak(Mayo Clinic), Simon Kung(Mayo Clinic), Jennifer R. Geske(Mayo Clinic in Florida), Phillip J. Schulte(Mayo Clinic), Vanessa Pazdernik(Mayo Clinic in Florida), Mark A. Frye(Universidade Federal do Rio Grande do Sul)
Cited by 63
Related Papers
The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders
|American Journal of Psychiatry|2013|754
Association of Mediterranean Diet with Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis
|Journal of Alzheimer s Disease|2014|664
Neuropsychological and Behavioral Outcomes after Exposure of Young Children to Procedures Requiring General Anesthesia
|Anesthesiology|2018|587
Derivation and Validation of Automated Electronic Search Strategies to Extract Charlson Comorbidities From Electronic Medical Records
|Mayo Clinic Proceedings|2012|209
Augmentation strategies for treatment resistant major depression: A systematic review and network meta-analysis
|Journal of Affective Disorders|2022|208